Adicet Bio, Inc.
NASDAQAdicet Bio just delivered a Q1 earnings beat — but the market's reaction this week captures the contradiction at the heart of this stock: a credible scientific narrative, a unanimous analyst buy consensus, and a price still down 7% on the week. The most notable development this week is Jefferies stepping in. The firm assumed coverage on May 5 with a Buy rating and a $19 price…
Snapshot as of 28 Jun 2026
Adicet Bio just delivered a Q1 earnings beat — but the market's reaction this week captures the contradiction at the heart of this stock: a credible scientific narrative, a unanimous analyst buy consensus, and a price…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ACET — free to start on ORTEX.
Sign up for free →Open ACET on ORTEX